Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
| Generic Name | Brand Name |
|---|---|
| alteplase | Activase |
Tissue plasminogen activator can be used to treat some people who are having a stroke caused by a blood clot (ischemic stroke). It is given in a vein (intravenously, or IV) and in some cases may be given directly into an artery.
The medicine works best if it is given right away after stroke symptoms begin. Strict criteria must be met in order to use the medicine. The medicine can be used to prevent disability after a stroke.
All medicines have side effects. But many people don't feel the side effects, or they are able to deal with them. Ask your pharmacist about the side effects of each medicine you take. Side effects are also listed in the information that comes with your medicine.
Here are some important things to think about:
Common side effects of this medicine include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Tissue plasminogen activator should be given right away after the first symptoms of stroke start. The person and/or family members need to provide as much information as possible about what symptoms the person had and when they began. This helps determine whether giving t-PA would be helpful. If it has been too long since the symptoms started, the medicine is unlikely to benefit the person. Other strict criteria also must be met before the medicine can be given.
Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It's also a good idea to know your test results and keep a list of the medicines you take.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Hacke W, et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 359(13): 1317–1329.
- Del Zoppo GJ, et al. (2009). Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association. Stroke, 40(8): 2945–2948.
Last Revised: January 7, 2011
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Medical centers in #SiouxFalls, #Fargo & #Bismarck recognized by @American_Heart for heart-attack care http://t.co/00Gl6HpKNH